Safeguard Investment Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Safeguard Investment Advisory Group's PFE Position: Q2 2026 in Review
Safeguard Investment Advisory Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 9,281 shares — an estimated $261K sold.
Safeguard Investment Advisory Group first reported a position in PFE in Q4 2020 and held it in 16 quarters. The position peaked at $484K in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Safeguard Investment Advisory Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Safeguard Investment Advisory Group sold 9,281 Pfizer shares in Q2 2026, an estimated $261K.
- Safeguard Investment Advisory Group first reported a position in Pfizer in Q4 2020 and held it in 16 quarters.
- Safeguard Investment Advisory Group's Pfizer position peaked at $484K in Q4 2022.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Safeguard Investment Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.